Oberweis Asset Management »

Catalyst Pharmaceutical Partners shares owned by Oberweis Asset Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Oberweis Asset Management from 13F filings

Historical chart of Oberweis Asset Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Oberweis Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Oberweis Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.9M 349k 16.81
2023-09-30 $3.4M 294k 11.69
2023-06-30 $2.5M 183k 13.44
2023-03-31 $2.4M 147k 16.58
2022-12-31 $1.8M 97k 18.60

More positions owned by Oberweis Asset Management

Constellium Se cl a (CSTM)
Axcelis Technologies (ACLS)
Aehr Test Systems (AEHR)
Alphatec Holdings (ATEC)
Weatherford Intl Ordf (WFRD)
Amphastar Pharmaceuticals (AMPH)
Veracyte (VCYT)
Applied Optoelectronics (AAOI)
Transmedics Group (TMDX)
Perion Network (PERI)
Universal Display Corporation (OLED)
Adma Biologics (ADMA)
Camtek (CAMT)
Vertiv Holdings Llc vertiv holdings (VRT)
Axonics Modulation Technolog (AXNX)

View all positions for Oberweis Asset Management

Top funds holding Catalyst Pharmaceutical Partners

Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Royce & Associates
Robeco Investment Management
Jacobs Levy Equity Management
Opaleye Management
LSV Asset Management
T. Rowe Price Associates
Henderson Group
Goldman Sachs Group
Charles Schwab Investment Management
Jupiter Asset Management
Bank of New York Mellon
Bank of America Corporation

View all funds holding Catalyst Pharmaceutical Partners